World Stroke Organization 
Excelente
Juan Roberto Escareño Espericueta
;
#MondayTip
From WSO/ICAA-A Cerebral Amyloid Angiopathy Statement
🎯Management of antithrombotics in #CAA requires individualized, risk-balanced decision-making, given CAA’s intrinsically high risk of ICH
Phenotypic markers by @a_charidimou
Statement: https://doi.org/10.1177/17474930251365861
🔜Webinar on #StrokeSpasticity Management, Dec 11th, 3pm (CET)
👩💻Topics include global impact, optimizing #botulinumtoxin therapy & exploring #telerehabilitation to enhance recovery & patient outcomes
🖇️𝐑𝐄𝐆𝐈𝐒𝐓𝐄𝐑: https://us02web.zoom.us/webinar/register/WN_gMpCwNTPSMWLKPkwSoKYFw#/registration
#StrokeEducation @Bayer
🔴We are #live! Join experts Ellis van Etten, @a_charidimou, David Werring and @SMGreenbergNeur to learn more about the diagnosis and management of #CerebralAmyloidAngiopathy (CAA).
𝐂𝐎𝐍𝐍𝐄𝐂𝐓 𝐍𝐎𝐖: https://us02web.zoom.us/webinar/register/WN_z_OuKtEJQSui8CWbhP17cA#/
@WorldStrokeOrg @IntJStroke #StrokeEducation
What happened in #StrokeEducation in November? Time to read our newsletter!
🗞️https://www.world-stroke-academy.org/news/november-newsletter-2/
🟢Webinars
🟢PoM: Pre-Hospital Care w/ @IntJStroke
🟢WSC2025 TV Studio w/ @OruenCNS
🟢Meet The Trialist w/ @Bayer
🟢#MondayTips by @interneurona
𝐇𝐚𝐩𝐩𝐲 𝐋𝐞𝐚𝐫𝐧𝐢𝐧𝐠!
